Global Chenodeoxycholic Acid 麻豆原创 Growth 2025-2031

Publication ID:

LPI01252521

Publication Date:

January 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Chenodeoxycholic Acid market size is predicted to grow from US$ 405 million in 2025 to US$ 582 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.
Chenodeoxycholic acid (also known as chenodesoxycholic acid, chenocholic acid and 3伪,7伪-dihydroxy-5尾-cholan-24-oic acid) is a bile acid. It occurs as a white crystalline substance insoluble in water but soluble in alcohol and acetic acid, with melting point at 165鈥�167 掳C. Salts of this carboxylic acid are called chenodeoxycholates. Chenodeoxycholic acid is one of the main bile acids produced by the liver.
According to the type, Chenodeoxycholic Acid can be divided into 80-90% purity and 95-98% purity. In 2019, the sales of 80-90% purity accounted for more than 97%.
In 2019, the global Chenodeoxycholic Acid market is led by China. Europe is the second-largest region-wise market.
The 鈥淐henodeoxycholic Acid Industry Forecast鈥� looks at past sales and reviews total world Chenodeoxycholic Acid sales in 2024, providing a comprehensive analysis by region and market sector of projected Chenodeoxycholic Acid sales for 2025 through 2031. With Chenodeoxycholic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chenodeoxycholic Acid industry.
This Insight Report provides a comprehensive analysis of the global Chenodeoxycholic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chenodeoxycholic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Chenodeoxycholic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chenodeoxycholic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chenodeoxycholic Acid.
This report presents a comprehensive overview, market shares, and growth opportunities of Chenodeoxycholic Acid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
80-90% Purity
95-98% Purity
Segmentation by Application:
Ursodeoxycholic Acid Synthesis
Steroids and Steroid Derivatives
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICE Group
Zhongshan Belling Biotechnology
PharmaZell GmbH
Suzhou Tianlu Bio-pharmaceutical
Daewoong
Linyi Tianli Biochemical
Changde Yungang Biotechnology
Guanghan Yikang Biological
Tianjin NWS Biotechnology and Medicine
Shandong Zhongjing Biological
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chenodeoxycholic Acid market?
What factors are driving Chenodeoxycholic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chenodeoxycholic Acid market opportunities vary by end market size?
How does Chenodeoxycholic Acid break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Chenodeoxycholic Acid Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chenodeoxycholic Acid by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chenodeoxycholic Acid by Country/Region, 2020, 2024 & 2031
2.2 Chenodeoxycholic Acid Segment by Type
2.2.1 80-90% Purity
2.2.2 95-98% Purity
2.3 Chenodeoxycholic Acid Sales by Type
2.3.1 Global Chenodeoxycholic Acid Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Chenodeoxycholic Acid Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Chenodeoxycholic Acid Sale Price by Type (2020-2025)
2.4 Chenodeoxycholic Acid Segment by Application
2.4.1 Ursodeoxycholic Acid Synthesis
2.4.2 Steroids and Steroid Derivatives
2.5 Chenodeoxycholic Acid Sales by Application
2.5.1 Global Chenodeoxycholic Acid Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Chenodeoxycholic Acid Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Chenodeoxycholic Acid Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Chenodeoxycholic Acid Breakdown Data by Company
3.1.1 Global Chenodeoxycholic Acid Annual Sales by Company (2020-2025)
3.1.2 Global Chenodeoxycholic Acid Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Chenodeoxycholic Acid Annual Revenue by Company (2020-2025)
3.2.1 Global Chenodeoxycholic Acid Revenue by Company (2020-2025)
3.2.2 Global Chenodeoxycholic Acid Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Chenodeoxycholic Acid Sale Price by Company
3.4 Key Manufacturers Chenodeoxycholic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chenodeoxycholic Acid Product Location Distribution
3.4.2 Players Chenodeoxycholic Acid Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Chenodeoxycholic Acid by Geographic Region
4.1 World Historic Chenodeoxycholic Acid 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Chenodeoxycholic Acid Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chenodeoxycholic Acid Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chenodeoxycholic Acid 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Chenodeoxycholic Acid Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chenodeoxycholic Acid Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chenodeoxycholic Acid Sales Growth
4.4 APAC Chenodeoxycholic Acid Sales Growth
4.5 Europe Chenodeoxycholic Acid Sales Growth
4.6 Middle East & Africa Chenodeoxycholic Acid Sales Growth
5 Americas
5.1 Americas Chenodeoxycholic Acid Sales by Country
5.1.1 Americas Chenodeoxycholic Acid Sales by Country (2020-2025)
5.1.2 Americas Chenodeoxycholic Acid Revenue by Country (2020-2025)
5.2 Americas Chenodeoxycholic Acid Sales by Type (2020-2025)
5.3 Americas Chenodeoxycholic Acid Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chenodeoxycholic Acid Sales by Region
6.1.1 APAC Chenodeoxycholic Acid Sales by Region (2020-2025)
6.1.2 APAC Chenodeoxycholic Acid Revenue by Region (2020-2025)
6.2 APAC Chenodeoxycholic Acid Sales by Type (2020-2025)
6.3 APAC Chenodeoxycholic Acid Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chenodeoxycholic Acid by Country
7.1.1 Europe Chenodeoxycholic Acid Sales by Country (2020-2025)
7.1.2 Europe Chenodeoxycholic Acid Revenue by Country (2020-2025)
7.2 Europe Chenodeoxycholic Acid Sales by Type (2020-2025)
7.3 Europe Chenodeoxycholic Acid Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chenodeoxycholic Acid by Country
8.1.1 Middle East & Africa Chenodeoxycholic Acid Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chenodeoxycholic Acid Revenue by Country (2020-2025)
8.2 Middle East & Africa Chenodeoxycholic Acid Sales by Type (2020-2025)
8.3 Middle East & Africa Chenodeoxycholic Acid Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chenodeoxycholic Acid
10.3 Manufacturing Process Analysis of Chenodeoxycholic Acid
10.4 Industry Chain Structure of Chenodeoxycholic Acid
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chenodeoxycholic Acid Distributors
11.3 Chenodeoxycholic Acid Customer
12 World Forecast Review for Chenodeoxycholic Acid by Geographic Region
12.1 Global Chenodeoxycholic Acid 麻豆原创 Size Forecast by Region
12.1.1 Global Chenodeoxycholic Acid Forecast by Region (2026-2031)
12.1.2 Global Chenodeoxycholic Acid Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chenodeoxycholic Acid Forecast by Type (2026-2031)
12.7 Global Chenodeoxycholic Acid Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ICE Group
13.1.1 ICE Group Company Information
13.1.2 ICE Group Chenodeoxycholic Acid Product Portfolios and Specifications
13.1.3 ICE Group Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ICE Group Main Business Overview
13.1.5 ICE Group Latest Developments
13.2 Zhongshan Belling Biotechnology
13.2.1 Zhongshan Belling Biotechnology Company Information
13.2.2 Zhongshan Belling Biotechnology Chenodeoxycholic Acid Product Portfolios and Specifications
13.2.3 Zhongshan Belling Biotechnology Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zhongshan Belling Biotechnology Main Business Overview
13.2.5 Zhongshan Belling Biotechnology Latest Developments
13.3 PharmaZell GmbH
13.3.1 PharmaZell GmbH Company Information
13.3.2 PharmaZell GmbH Chenodeoxycholic Acid Product Portfolios and Specifications
13.3.3 PharmaZell GmbH Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 PharmaZell GmbH Main Business Overview
13.3.5 PharmaZell GmbH Latest Developments
13.4 Suzhou Tianlu Bio-pharmaceutical
13.4.1 Suzhou Tianlu Bio-pharmaceutical Company Information
13.4.2 Suzhou Tianlu Bio-pharmaceutical Chenodeoxycholic Acid Product Portfolios and Specifications
13.4.3 Suzhou Tianlu Bio-pharmaceutical Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Suzhou Tianlu Bio-pharmaceutical Main Business Overview
13.4.5 Suzhou Tianlu Bio-pharmaceutical Latest Developments
13.5 Daewoong
13.5.1 Daewoong Company Information
13.5.2 Daewoong Chenodeoxycholic Acid Product Portfolios and Specifications
13.5.3 Daewoong Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Daewoong Main Business Overview
13.5.5 Daewoong Latest Developments
13.6 Linyi Tianli Biochemical
13.6.1 Linyi Tianli Biochemical Company Information
13.6.2 Linyi Tianli Biochemical Chenodeoxycholic Acid Product Portfolios and Specifications
13.6.3 Linyi Tianli Biochemical Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Linyi Tianli Biochemical Main Business Overview
13.6.5 Linyi Tianli Biochemical Latest Developments
13.7 Changde Yungang Biotechnology
13.7.1 Changde Yungang Biotechnology Company Information
13.7.2 Changde Yungang Biotechnology Chenodeoxycholic Acid Product Portfolios and Specifications
13.7.3 Changde Yungang Biotechnology Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changde Yungang Biotechnology Main Business Overview
13.7.5 Changde Yungang Biotechnology Latest Developments
13.8 Guanghan Yikang Biological
13.8.1 Guanghan Yikang Biological Company Information
13.8.2 Guanghan Yikang Biological Chenodeoxycholic Acid Product Portfolios and Specifications
13.8.3 Guanghan Yikang Biological Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Guanghan Yikang Biological Main Business Overview
13.8.5 Guanghan Yikang Biological Latest Developments
13.9 Tianjin NWS Biotechnology and Medicine
13.9.1 Tianjin NWS Biotechnology and Medicine Company Information
13.9.2 Tianjin NWS Biotechnology and Medicine Chenodeoxycholic Acid Product Portfolios and Specifications
13.9.3 Tianjin NWS Biotechnology and Medicine Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Tianjin NWS Biotechnology and Medicine Main Business Overview
13.9.5 Tianjin NWS Biotechnology and Medicine Latest Developments
13.10 Shandong Zhongjing Biological
13.10.1 Shandong Zhongjing Biological Company Information
13.10.2 Shandong Zhongjing Biological Chenodeoxycholic Acid Product Portfolios and Specifications
13.10.3 Shandong Zhongjing Biological Chenodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shandong Zhongjing Biological Main Business Overview
13.10.5 Shandong Zhongjing Biological Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.